l-carnitine 1st phorm Energy 1st Phorm L Carnitine with

The discovery of protein aggregates and causative mutations in FUS/TLS 2,3 and TDP-43 (refs 4, 5, 6, 7), two strikingly similar RBPs, as dominant causes of both the fatal adult motor neuron disease amyotrophic lateral sclerosis (ALS) and the second most frequent degenerative cognitive disorder (frontal temporal degeneration (FTD)) has initiated a paradigm shift in research on this pair of diseases, with errors in RNA maturation now a focus as a central component of disease mechanism 1,2,3,4,5,6,7,8

ORAC, DPPH and one of TF, TP or FRAP

To this, 51 mg of 4-Cyano-4-[(dodecylsulfanylthiocarbonyl)sulfanyl]pentanoic acid was added, followed by 100 L of a 78 mg/mL stock solution of AIBN in DCB

10.1007/s13577-021-00580-6 271 WuY.DingY.RamprasathT.ZouM